Merck & Co. 10Q 2018 Q1 Quarterly report | MRK Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: acute, admission, Alimta, answer, arose, arrangement, ASC, ASCO, ASU, Attorney, AUD, Australian, backlog, bacterial, basket, begun, biennial, Brabant, BRCA, causation, Cavatak, centralized, channel, Chinese, cisplatin, civil, clawback, coexistence, colistimethate, Colistin, comparison, Conference, confirmatory, conjugate, context, Counsel, coupon, criminal, criteria, customary, cyclase, Daubert, Dec, Decree, Department, depict, disproportionate, DMC, Dutch, Ebola, Eisai, enablement, enacted, enactment, endometrial, England, entitled, entrance, epidermal, epithelial, EUAL, expedient, factor, fallopian, fine, foregoing, geographic, GILTI, guanylate, healthy, heart, hospital, imipenem, immunogenicity, immunology, injunction, inspected, Inspector, intermediate, interpretation, intratumoral, investee, invited, invoice, invoiced, Ireland, Journal, Jurisdiction, Justice, Kabi, kidney, Labour, lack, Lancet, legislation, legislatively, lenvatinib, Lenvima, Levitra, mandated, Maryland, Maxalt, mentioned, merger, mesylate, Ministry, multinational, mutation, Mylan, nephrotoxicity, NewLink, NJ, oncolytic, Opportunistic, Organization, outbreak, paclitaxel, payback, peritoneal, PFS, platinum, PMBCL, Pneumococci, population, Portugal, preferential, preferentially, PRIME, prioritization, promise, proprietary, Prosecutor, Province, provisional, publicly, published, question, radically, rare, ratably, recast, referenced, releasing, relebactam, remitted, renewing, rental, residual, rest, restated, satisfied, scale, seasoned, SEC, secondary, sequentially, sGC, shelf, shipment, simultaneously, Singapore, Solicitor, soluble, Spain, sponsored, stranded, strong, substance, suspected, TCJA, technical, thromboembolic, tolerability, toxicity, tube, turn, tyrosine, unaffected, unbudgeted, undistributed, unsettled, usage, Variation, vast, vericiguat, virology, Welfare, worsening

Removed: achieved, Agency, ALK, Allergan, allergic, allergy, antibiotic, antibody, asthma, bacteremia, bill, BMS, Bravecto, brentuximab, broadly, cancellation, cardiac, chloride, claimed, closing, Colaw, communication, complicated, composition, coordinate, corticosteroid, Corticotropin, Cortrophin, Cubicin, daptomycin, delay, deprioritized, dihydrate, direct, discussing, domestic, earned, EC, EGFR, element, ertugliflozin, ESI, etonogestrel, examination, floating, formalized, furoate, genomic, genotype, glycemic, greater, GT, Hospira, Hydroxide, IDO, implant, impracticable, increased, incremental, incur, indirect, ineligible, infarction, inhaled, innovative, IOmet, Lederle, letter, Lifetec, lose, lowered, manufacturer, metabolism, metformin, mometasone, monohydrate, montelukast, myeloma, myocardial, nasal, occurring, offering, Ono, people, peripheral, Pfizer, Pharma, potassium, preclinical, prescribing, presiding, proceed, prohibited, proportion, prospectively, PSC, putative, receiving, recommend, rehearing, reinvested, relationship, repatriated, reviewing, ribavirin, Savior, score, skin, SPMSD, Squibb, Steering, stem, stream, subdermal, supplement, susceptible, swine, system, TDO, terminate, terminated, testing, Teva, Thierry, thrombotic, trade, transplant, tumor, unconditionally, unremitted, vedotin, voted, XR, Zerbaxa, Zinc, Zontivity




Dated: May 8, 2018	/s/ Kenneth C. Frazier
	Name: Title:	KENNETH C. FRAZIER Chairman, President and Chief Executive Officer

Merck & Co. (MRK) 10-Q2018 Q1 Quarterly report

Content analysis